Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Good Night, Sleep Tight with affron® Natural Melatonin Booster


      News provided by

      Pharmactive Biotech Products, S.L.

      Sep 13, 2023, 07:00 ET

      Share this article

      Share this article


      Pure, clean-label support for natural melatonin production from Pharmactive Biotech's saffron extract

      MADRID, Sept. 13, 2023 /PRNewswire/ -- Results of a new study demonstrate that the standardized affron® saffron extract boosts the body's endogenous production of melatonin. Melatonin—nicknamed the "sleep hormone"—is naturally produced in the body from the dietary amino acid tryptophan. Among other roles, melatonin helps synchronize the sleep–wake cycle and other circadian rhythms and helps adjust for seasonal changes in sleep timing. It has become one of the most commonly used treatment for sleep disorders.

      Continue Reading
      Good Night, Sleep Tight with affron® Natural Melatonin Booster
      Good Night, Sleep Tight with affron® Natural Melatonin Booster

      Pharmactive Biotech Products, SLU, owners, and manufacturer of affron brand natural saffron ingredient, prized, for its action in maintaining positive mood, induce relaxation, improve occasional stress, and mitigating psychological symptoms of menopause, announces results of a new in vivo study that shows that affron® can help boost the body's endogenous production of melatonin.

      "Results of a previous clinical study showed that Pharmactive's potent saffron extract significantly improves sleep quality, helps to support mood balance after awakenings, reduce sleep-onset latency, ease difficulties in falling asleep, and allows for more continuous and less-interrupted slumber," says Alberto Espinel, Open Innovation & IP Director. "The new study1 clarifies the mechanism for affron's positive effects on sleep, providing solid scientific support to the previous studies."

      The placebo-controlled animal study was designed to assess the effects of affron on melatonin synthesis and the Kynurenine Pathway. Melatonin is a hormone that is synthesized in the pineal gland from tryptophan (only a very minor part of the available tryptophan is used for melatonin synthesis), which is first converted into serotonin—the so-called "feel-good" hormone—and finally into melatonin.

      Tryptophan also can follow another pathway and be enzymatically transformed into several molecules on the kynurenine pathway. This unbalanced pathway is negatively involved in several biological processes. The results of the new study indicate that affron® inhibits the enzymes that allow this conversion from tryptophan to kynurenine metabolites, demonstrating the antioxidant and anti-inflammatory properties of affron, while promoting the synthesis of enzymes responsible for transforming tryptophan into melatonin, resulting in a significative improvement of plasma melatonin levels.

      In summary, the study shows unequivocally that affron has an effect on sleep quality because it stimulates endogenous melatonin production. Furthermore, it was observed throughout this process that the consumption of affron is safe and has no toxic effects on the body.

      Lack of sleep has long been recognized by the US National Institutes of Health as a global crisis, a situation only exacerbated by the recent pandemic. A number of surveys suggest some two thirds of people report getting insufficient sleep. Insufficient Sleep is defined by The Sleep Foundation as "curtailed sleep that persists for three months or longer," as well as "poor sleep that occurs because of sleep fragmentation or other disruptions."

      Long-term sleep deficit (defined as fewer than seven hours per night)—which now affects around a third of adults—has been linked to a host of physical, cognitive, and emotional diseases and dysfunctions that range from increased risks of obesity, high blood pressure, diabetes to heightened levels of occasional stress and low mood.

      Twice as many persons are taking daily sleep aids as there were in 2010, according to the Centers for Disease Control, and in the past five years, melatonin has been increasingly favored by consumers as an aid to better slumber. Used as directed, melatonin is a safe and effective, natural supplement that can help users fall asleep more quickly and to get longer, and better quality, sleep. However, a study published last spring in the Journal of the American Medical Association revealed that nearly nine in 10 melatonin supplements were mislabelled, having inaccurately presented amounts of the hormone and some having none whatsoever.

      The primary conclusion of the new in vivo study is that, with affron, the body can more efficiently generate its own melatonin without the need for melatonin supplements.

      This is positive because it benefits population groups that do not metabolize exogen melatonin properly, such as the elderly. Yet affron also is safe and effective for use by teenagers, making it a perfect ally for treating occasional sleeplessness in this often sleep-deprived age group. Moreover, no negative effects such as headaches, dizziness, drowsiness, etc. were observed.

      "Better sleep is as much about good sleep as it is about duration of sleep," explains Espinel. "Supported by previous studies on affron's ability to act as a natural sleeping agent, this latest study demonstrates that it is actively involved in aiding the body's natural capacity to fall asleep and stay asleep."

      Pharmactive works with selected saffron farmers, supporting local and sustainable agriculture to ensure that the stigmas of Crocus sativus L. used are always of the highest quality. Their craft has been part of their cultural heritage for centuries and consists of traditional methods that bring unique characteristics to the final product. The fresh stigmas are dried on-site, immediately after harvesting, to ensure maximum stability of the active ingredients.

      Affron® is naturally extracted from saffron via a proprietary extraction process AFF®ON Cool-Tech, using zero chemicals, with less energy and less industrial processing, using only water. Furthermore, thanks to the exhaustive quality controls carried out, it is possible to certify that the saffron used for the production of affron is 100% Crocus sativus L. It is water-soluble and versatile across multiple applications at a recommended daily amount of 28mg for improving mood and occasional stress, and 14mg one hour before bedtime to improve sleep quality.

      About Pharmactive

      Pharmactive Biotech Products, SLU, is a Madrid-based pioneering biotechnology company that develops and manufactures differentiated natural ingredients supported by science, such as damiana extract, pure saffron extract, and aged black garlic. The company's mission is to make a daily positive and significant impact on people's health and well-being through premium botanical ingredients backed by scientific studies and approved by ethics committees.

      Be sure to visit Pharmactive at Vitafoods Asia, 20-22 September (Booth #E31), and at Supply Side West, 25-26 October (Booth #2965).

      For more information, contact:

      Company Contact:

      Pharmactive Biotech Products, S.L.U.
      Cristian Conde Garrido
      Head of Marketing
      Tel: +34 640776354
      Email: Cristian.conde@pharmactive.eu          
      Twitter: @Pharmactive_SP
      Web: www.pharmactive.eu

      Press Contact:

      NutriPR
      Liat Simha
      Tel: +972-9-9742893
      E-mail: liat@nutripr.com
      Twitter: @NutriPR_
      Web: www.nutripr.com

      Photo - https://mma.prnewswire.com/media/2208718/affron.jpg

      SOURCE Pharmactive Biotech Products, S.L.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.